Introduction
cancer, PDAC
PANCREATIC DUCTAL ADENOCARCINOMA, CANCER, STILL
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer mortality with poor overall survival (OS) [Peptide vaccine GV1001 comprises 16 amino acids derived from the catalytic subunit of human telomerase reverse transcriptase (hTERT) [Still, there have been no further investigations to prove the role of eotaxin in PDAC under GV1001 treatment. Hence, we planned a repeated Phase III randomised controlled trial, named KG4/2015, to re-analyse the efficacy of GV1001 therapy in Korean patients with PDAC who have high serum eotaxin levels.